The role of BCL9 genetic variation as a biomarker for hepatitis C-related hepatocellular carcinoma in Egyptian patients

MLA

Eman Abd El Razek Abbas, et al. “The Role of BCL9 Genetic Variation as a Biomarker for Hepatitis C-Related Hepatocellular Carcinoma in Egyptian Patients.” Journal of Genetic Engineering and Biotechnology, vol. 20, no. 1, Jan. 2022, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s43141-021-00282-4.

APA

Eman Abd El Razek Abbas, Ahmed Barakat Barakat, Mohamed Hassany, & Samar Samir Youssef. (2022). The role of BCL9 genetic variation as a biomarker for hepatitis C-related hepatocellular carcinoma in Egyptian patients. Journal of Genetic Engineering and Biotechnology, 20(1), 1–9. https://doi.org/10.1186/s43141-021-00282-4

Chicago

Eman Abd El Razek Abbas, Ahmed Barakat Barakat, Mohamed Hassany, and Samar Samir Youssef. 2022. “The Role of BCL9 Genetic Variation as a Biomarker for Hepatitis C-Related Hepatocellular Carcinoma in Egyptian Patients.” Journal of Genetic Engineering and Biotechnology 20 (1): 1–9. doi:10.1186/s43141-021-00282-4.